Healthcare provider profile · identity verified

Michael Joseph Conigliaro

Nurse Practitioner · JACKSONVILLE, FL · NPI 1205483898

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	468	77
Levothyroxine Sodium	Levothyroxine Sodium	363	62
Amlodipine Besylate	Amlodipine Besylate	285	51
Furosemide	Furosemide	261	48
Gabapentin	Gabapentin	255	40
Potassium Chloride	Potassium Chloride	253	40
Pantoprazole Sodium	Pantoprazole Sodium	239	40
Donepezil Hcl	Donepezil Hcl	220	39
Sertraline Hcl	Sertraline Hcl	213	37
Lisinopril	Lisinopril	211	40
Quetiapine Fumarate	Quetiapine Fumarate	205	45
Tamsulosin Hcl	Tamsulosin Hcl	200	39
Metoprolol Tartrate	Metoprolol Tartrate	192	22
Eliquis	Apixaban	154	31
Losartan Potassium	Losartan Potassium	149	23
Mirtazapine	Mirtazapine	148	22
Metoprolol Succinate	Metoprolol Succinate	146	26
Trazodone Hcl	Trazodone Hcl	143	22
Clopidogrel	Clopidogrel Bisulfate	132	20
Omeprazole	Omeprazole	126	20
Memantine Hcl	Memantine Hcl	125	25
Simvastatin	Simvastatin	122	17
Alprazolam	Alprazolam	99	20
Metformin Hcl	Metformin Hcl	98	20
Escitalopram Oxalate	Escitalopram Oxalate	94	16
Xarelto	Rivaroxaban	90	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	89	19
Hydrochlorothiazide	Hydrochlorothiazide	81	12
Carvedilol	Carvedilol	80	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	77	52
Montelukast Sodium	Montelukast Sodium	74	11
Finasteride	Finasteride	73	14
Allopurinol	Allopurinol	71	14
Prednisone	Prednisone	71	51
Duloxetine Hcl	Duloxetine Hcl	66	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	45
Hydralazine Hcl	Hydralazine Hcl	60	suppressed
Nystatin	Nystatin	60	28
Levetiracetam	Levetiracetam	59	suppressed
Metformin Hcl Er	Metformin Hcl	59	13
Buspirone Hcl	Buspirone Hcl	58	11
Pravastatin Sodium	Pravastatin Sodium	55	suppressed
Divalproex Sodium	Divalproex Sodium	54	suppressed
Torsemide	Torsemide	52	suppressed
Bupropion Xl	Bupropion Hcl	49	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	44	40
Olanzapine	Olanzapine	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	17
Fluticasone Propionate	Fluticasone Propionate	42	14
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Celecoxib	Celecoxib	40	suppressed
Midodrine Hcl	Midodrine Hcl	40	12
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Famotidine	Famotidine	39	11
Pregabalin	Pregabalin	39	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Myrbetriq	Mirabegron	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Ketoconazole	Ketoconazole	33	12
Naproxen	Naproxen	33	15
Tramadol Hcl	Tramadol Hcl	33	17
Entresto	Sacubitril/Valsartan	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	26
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	29	suppressed
Atenolol	Atenolol	28	suppressed
Digoxin	Digoxin	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Loperamide	Loperamide Hcl	28	13
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	16
Lorazepam	Lorazepam	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Spironolactone	Spironolactone	24	suppressed
Ondansetron Odt	Ondansetron	23	17
Propranolol Hcl	Propranolol Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	20	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	20	14
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Verapamil Hcl	Verapamil Hcl	20	suppressed
Erythromycin	Erythromycin Base	19	suppressed
Gemtesa	Vibegron	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Glipizide	Glipizide	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Levofloxacin	Levofloxacin	16	14
Methocarbamol	Methocarbamol	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Progesterone	Progesterone, Micronized	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Tacrolimus	Tacrolimus	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Baclofen	Baclofen	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Lactulose	Lactulose	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Travoprost	Travoprost	12	suppressed
Valsartan	Valsartan	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error